Skip to content

Clinical trials

Phase 2 Hepatitis C, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hepatitis C, Chronic Phase: Phase 2 Clear all

182 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20013
20023
20032
20045
200515
20069
200715
200812
200912
20109
201125
201218
201317
20148
201511
20168
20172
20183
20192
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed161
Unknown status12
Terminated8
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Gilead Sciences16
Merck Sharp & Dohme LLC16
Hoffmann-La Roche15
AbbVie7
Vertex Pharmaceuticals Incorporated6
Boehringer Ingelheim5
Bristol-Myers Squibb5
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)5
Romark Laboratories L.C.5
AbbVie (prior sponsor, Abbott)4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hepatitis C, Chronic182
Hepatitis C65
Hepatitis8
Liver Diseases7
Fibrosis5
Virus Diseases5
HIV Infections4
Hepatitis, Chronic3
Infections3
Liver Cirrhosis3

Trials

Showing 26 to 50 of 182. Each trial links to its page on Pharma Observatory.

82 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.